Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Satellos Bioscience Inc. (MSLE) had Income from Continuous Operations of $-11.72M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-11.72M |
|
-- |
|
-- |
|
$12.16M |
|
$-12.16M |
|
$0.49M |
|
$-11.67M |
|
$-11.67M |
|
$-11.72M |
|
|
Income from Continuous Operations |
$-11.72M |
$-11.72M |
|
$-11.72M |
|
$-12.16M |
|
$-12.16M |
|
20.83M |
|
20.83M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$65.76M |
|
$0.01M |
|
$0.01M |
|
$65.77M |
|
$5.86M |
|
-- |
|
-- |
|
$5.86M |
|
$59.91M |
|
$59.91M |
|
$59.91M |
|
20.84M |
|
| Cash Flow Statement Financials | |
$-17.61M |
|
$-36.68M |
|
$51.94M |
|
$9.80M |
|
$7.39M |
|
$-2.41M |
|
$1.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.56% |
|
-19.56% |
|
-17.82% |
|
-19.56% |
|
$2.87 |
|
$-0.85 |
|
$-0.85 |
|